It's Merck vs. Merck in Facebook "vanity URL" fracas

Share this article:

Facebook shut down Facebook.com/Merck after Merck KGaA announced plans to take legal action “based on the apparent takeover of its Facebook page” by its US cousin, Merck & Co.

The social media behemoth, which unwrapped plans for an initial public offering in November, has essentially told the two companies that they need to work the conflict out for themselves, saying that its assignment of the URL to the US company was “an administrative error.”

“We have removed the vanity URL,” said Facebook's Andrew Noyes, manager, public policy communications. “Facebook.com/Merck will be unavailable unless and until the two companies mutually agree that one can use it.” Either company, he added, is welcome to create a new username or vanity URL for themselves.

The fracas over the Facebook address is nothing more than a “tempest in a teapot,” according to a spokesman for Merck & Co., who noted that the faceoff has not had an effect on the company's Facebook presence since the so-called “vanity URL” simply redirected visitors to the US-based drug maker's page. Moreover, he added, it's a non-issue, since most people who get to the page find it through a search rather than by typing in a URL. In fact, the publicity has netted Merck & Co. “hundreds” of new followers over the past few days.

At issue is a pre-action disclosure filed with the New York Supreme Court and dated Nov. 21, stating that the “misappropriation” of the URL by “a similarly-named and unrelated competitor” is “causing harm” to the German firm.

“All I can tell you,” a Merck KGaA spokesman said, “is we are looking into the matter.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.